Boiron SA (EPA:BOI)
France
· Delayed Price · Currency is EUR 26.80
-0.20 (-0.74%)
Mar 9, 2026, 5:35 PM CET
Boiron Revenue
Boiron had revenue of 245.65M EUR in the half year ending June 30, 2025, with 2.40% growth. This brings the company's revenue in the last twelve months to 504.86M, up 4.80% year-over-year. In the year 2024, Boiron had annual revenue of 487.56M, down -1.15%.
Revenue (ttm)
504.86M
Revenue Growth
+4.80%
P/S Ratio
0.93
Revenue / Employee
184.52K
Employees
2,736
Market Cap
468.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 487.56M | -5.69M | -1.15% |
| Dec 31, 2023 | 493.25M | -40.99M | -7.67% |
| Dec 31, 2022 | 534.24M | 79.04M | 17.36% |
| Dec 31, 2021 | 455.20M | -58.38M | -11.37% |
| Dec 31, 2020 | 513.58M | -43.54M | -7.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sanofi | 46.72B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| Vetoquinol | 532.39M |
| Valneva SE | 179.91M |
| MedinCell | 32.44M |
| Equasens Société anonyme | 224.73M |